ViaLase CEO talks innovations in glaucoma treatment

Tibor Juhasz, CEO of ViaLase, Inc, discusses the company's development of a novel, noninvasive high-resolution OCT image-guided femtosecond laser technology for the treatment of open-angle glaucoma.

Related Videos

Related Content

Advertisement

March 9th 2025

Altris AI launches advanced glaucoma Optic Disc Analysis module

December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

March 7th 2025

New analysis on Mont Blanc Phase 3 trial for NCX 470 for patients with OAG released by Nicox

November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

March 5th 2025

The search for an antifibrotic drug for use with pediatric glaucoma devices

March 4th 2025

Ophthalmology balances the promises and challenges of AI

Related Content

Advertisement

March 9th 2025

Altris AI launches advanced glaucoma Optic Disc Analysis module

December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

March 7th 2025

New analysis on Mont Blanc Phase 3 trial for NCX 470 for patients with OAG released by Nicox

November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

March 5th 2025

The search for an antifibrotic drug for use with pediatric glaucoma devices

March 4th 2025

Ophthalmology balances the promises and challenges of AI